Comparative effectiveness of upadacitinib versus ustekinumab in patients with moderately to severely active Crohn's disease: a matching-adjusted indirect comparison

被引:0
|
作者
Ma, C. [1 ]
Dubinsky, M. C. [2 ]
Axelrad, J. [3 ]
Anyanwu, S. [4 ]
Tran, J. [5 ,6 ]
Lacerda, A. [4 ]
Joshi, N. [4 ]
Griffith, J. [4 ]
机构
[1] Univ Calgary, Dept Med, Inflammatory Bowel Dis Clin, Calgary, AB, Canada
[2] Icahn Sch Med Mt Sinai, Div Pediat Gastroenterol & Nutr, New York, NY USA
[3] NYU Grossman Sch Med, Div Gastroenterol, Dept Med, New York, NY USA
[4] AbbVie Inc, Chicago, IL USA
[5] AbbVie Inc, Seattle, WA USA
[6] Univ Washington, Comparat Hlth Outcomes Policy & Econ Inst, Seattle, WA USA
来源
JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P1040
引用
收藏
页码:I1866 / I1867
页数:2
相关论文
共 50 条
  • [11] A MATCHING-ADJUSTED INDIRECT COMPARISON OF FILGOTINIB VERSUS TOFACITINIB FOR MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Lu, X.
    Gray, E.
    Xin, Y.
    Zhou, J.
    Jairath, V
    Lindsay, J. O.
    VALUE IN HEALTH, 2022, 25 (07) : S321 - S321
  • [12] Matching-Adjusted Indirect Comparisons of Filgotinib vs Vedolizumab, Tofacitinib, and Ustekinumab for Moderately to Severely Active Ulcerative Colitis
    Lu, Xiaoyan
    Zhou, Zheng-Yi
    Xin, Yiqiao
    Wang, Min-Jung
    Gray, Emma
    Jairath, Vipul
    Lindsay, James Oliver
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (01) : 64 - 77
  • [13] Matching-Adjusted Indirect Comparison of Etrasimod Versus Ozanimod for Clinical Response and Remission Among Patients With Moderately to Severely Active Ulcerative Colitis
    Jairath, Vipul
    Leahy, Thomas P.
    Potluri, Ravi
    Wosik, Karolina
    Gruben, David
    Cappelleri, Joseph C.
    Hur, Peter
    Bartolome, Lauren
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1058 - S1059
  • [14] Comparative Effectiveness of Bimekizumab and Ustekinumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison
    Mease, Philip J.
    Warren, Richard B.
    Nash, Peter
    Grouin, Jean-Marie
    Lyris, Nikos
    Taieb, Vanessa
    Eells, Jason
    McInnes, Iain B.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (05) : 1413 - 1423
  • [15] Comparative effectiveness of ozanimod versus dimethyl fumarate: results of a matching-adjusted indirect comparison
    Cohan, S.
    Kumar, J.
    Arndorfer, S.
    Zhu, X.
    Zivkovic, M.
    Tencer, T.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 140 - 140
  • [16] Effect of upadacitinib on extraintestinal manifestations in patients with moderately to severely active Crohn's disease
    Wright, Emily K.
    Colombel, Jean-Frederic
    Hudesman, David
    Cao, Qian
    Ghosh, Subrata
    Reinisch, Walter
    Lacerda, Ana
    Dubcenco, Elena
    Doshi, Chirag
    Anyanwu, Samuel
    Feng, Tian
    Rubin, David
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 159 - 160
  • [17] Comparative Clinical Efficacy of Sarilumab versus Upadacitinib over 12 Weeks: Matching-Adjusted Indirect Comparison Analysis
    Huizinga, Thomas
    Choy, Ernest
    Praestgaard, Amy
    van Hoogstraten, Hubert
    LaFontaine, Patrick R.
    Guyot, Patricia
    Aletaha, Daniel
    Mueller-Ladner, Ulf
    Tanaka, Yoshiya
    Curtis, Jeffrey R.
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [18] Upadacitinib improves symptomatic responses in patients with moderately to severely active Crohn's disease
    Blumenstein, I.
    Torres, J.
    Ma, C.
    Lindsay, J. O.
    Ungaro, R.
    Thin, L.
    Lacerda, A. P.
    Anyanwu, S. I.
    Garrison, A.
    Ford, S.
    Louis, E.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : II000 - I1001
  • [19] Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison
    Mahon, Ronan
    Tiwari, Santosh
    Koch, Mirja
    Ferraris, Matias
    Betts, Keith A.
    Wang, Yan
    Gao, Sophie
    Proot, Pascal
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (03)
  • [20] Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison
    Strand, Vibeke
    Betts, Keith A.
    Mittal, Manish
    Song, Jinlin
    Skup, Martha
    Joshi, Avani
    RHEUMATOLOGY AND THERAPY, 2017, 4 (02) : 349 - 362